Events

Talk

Discovery of Pharmacological Agents Emitted by Intestinal Bacteria

Talk

Microbiome-based biomarker predicts response to immune checkpoint inhibitor therapy in a melanoma meta-cohort independently of clinical features

Presentation

Biotech Showcase Digital 2021 Conference

Panel talk

Microbiome Based Precision Medicine: State Of The Science

Poster

Novel intestinal microbiome-derived peptides modulates immune cell activity and the tumor microenvironment

Talk

Multi-technology Meta-analysis Identifies Bacterial Signatures Delineating Clinical Response to Immune Checkpoint-Inhibitor Therapy in Melanoma Cohorts

  • Presented by:
    Divya Ravichandar, Ph.D.
  • Event:
    AMIA 2019 Annual Symposium
  • Venue:
    Washington Hilton, Washington, D.C.
  • Dates:
    November 16 - 20, 2019
Poster

Leveraging the Second Genome platform to develop microbiome-derived cancer immunotherapies

Talk

Targeting the Inflammasome through P2X7 receptor, and its Potential Implications for NASH Therapy

Talk & Poster

Metabolomic prediction from gut microbiome sequencing data: it is possible!

Poster

Multi-Technology Meta-Analysis Identifies Bacterial Signatures Delineating Clinical Response to Immune Checkpoint-Inhibitor Therapy in Melanoma Cohorts